Intraoperative Echocardiographic Evaluation of Pulmonary Vein Velocities and Outcomes in Lung Transplantation
1 other identifier
observational
100
1 country
1
Brief Summary
This study will evaluate if an association exists between levels of blood flow through the pulmonary veins and the incidence of graft dysfunction post operatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2017
CompletedFirst Posted
Study publicly available on registry
February 14, 2017
CompletedStudy Start
First participant enrolled
March 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 4, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 4, 2021
CompletedSeptember 9, 2021
September 1, 2021
3.9 years
January 7, 2017
September 7, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
incidence of graft dysfunction
To describe the relationship between intra-operative pulmonary vein systolic velocities and the incidence of graft dysfunction as defined by the International Society for Heart and Lung Transplantation (ISHLT).
at 30 days post-transplant
grade of graft dysfunction
To describe the relationship between intra-operative pulmonary vein systolic velocities and grade of graft dysfunction as defined by the International Society for Heart and Lung Transplantation (ISHLT).
at 30 days post-transplant
Secondary Outcomes (2)
All-cause mortality
at 30 days post-transplant
Hospital Length of Stay
From hospital admission to discharge up to one year.
Study Arms (1)
Lung Transplant Surgery
Subjects included in the study will have undergone a single or bilateral lung transplant surgery at The Ohio State University Wexner Medical Center between 01 JAN 2014 and 18 NOV 2016. No investigational intervention performed for this study.
Interventions
No investigational intervention for the purpose of this study was performed; data collected is retrospective data previously collected for non-research purposes.
Eligibility Criteria
The study population will include all surgical patients 18 years of age and older who underwent single or bilateral lung transplantation surgery during the period January 1st 2014 to November 18 2016 at Ohio State University Wexner Medical Center. Database screening for patient inclusion in retrospective analysis will be performed by designated personnel from the Anesthesiology Department or co-investigators entitled to work with patients' electronic data.
You may qualify if:
- All adult patients ≥ 18 years of age
- Having undergone single or bilateral lung transplantation surgery at Ohio State University Wexner Medical Center between January 1st 2014 and November 18th 2016
You may not qualify if:
- \. Patients ≤ 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Amar Bhatt, MD
Ohio State University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
January 7, 2017
First Posted
February 14, 2017
Study Start
March 17, 2017
Primary Completion
February 4, 2021
Study Completion
February 4, 2021
Last Updated
September 9, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share